Products

Names and Compounds of our Products 

Lundbeck has a broad range of products within brain diseases. With registered products in more than 100 countries, we leverage our global presence to bring innovative therapies to people living with brain diseases around the world. 
Neurological Disorders
Disease Area Trademark Compound First Registration Registered no. of Countries
Parkinson's disease Azilect® Rasagiline 2005 7
Alcohol dependence Selincro® Nalmefene 2013 34
Alzheimer's disease Ebixa®, Ebix®, Abixa®, Namenda® Memantine 2002 67
Migraine Vyepti® Eptinezumab 2020 1
Epilepsy Carnexiv® Carbamazepine 2016 1
Sabril® Vigabatrin 1993 2
Onfi®, Frisium® Clobazam 1975 3
Psychiatric Disorders
Disease Area Trademark Compound First Registration Registered no. of Countries
Depression, Anxiety Rexulti® Brexpiprazole 2015 23
Brintellix®, Trintellix®, Fonksera® Vortioxetine 2013 83
Cipralex®, Lexapro®, Sipralexa®, Seroplex®, Entact®, Lepax®, Premalex®, Prilect® Escitalopram Oxalate 2001 92
Cipramil®, Seropram®, Cipram®, Sepram®, Celexa®, Elopram®, Prisdal® Citalopram 1988 59
Deanxit® Flupentixol + melitracene 1971 21
Noritren®, Nortrilen®, Sensaval® Nortriptyline 1963 15
Saroten®, Sarotex®, Redomex®, Saroten Retard®, Sarotena® Amitriptyline 1960 11
Psychosis Rexulti® Brexpiprazole 2015 23
Abilify Maintena® Aripiprazole 2013 46
Serdolect® Sertindol 1996 30
Cisordinol®, Clopixol® Zuclopenthixol 1982 52
Cisordinol Depot®, Clopixol Depot®, Ciatyl-Z Depot® Zuclopenthixoldecanoate 1976 75
Fluanxol Depot®, Depixol®, Fluanxol LP®, Fluanxol Retard® Cis(Z)-Flupenticoldecanoate 1970 61
Fluanxol®, Fluanxol Mite®, Depixol® Flupentixol 1965 39
Truxal® Chlorprothixene 1959 16
Cisordinol-Acutard®, Clopixol-Acutard®, Clopixol-Acuphase®, Ciatyl-Z-Acuphase® Zuclopenthixolacetate 1986 63
Bipolar Disorder Saphris®, Sycrest® Asenapine 2010 1
Other Diseases
Disease Area Trademark Compound First Registration Registered no. of Countries
Other Nuvigil® Armodafinil 2015 1
Northera® Droxidopa 2014 1
Modiodal®, Vigil® Modafinil 2009 2

Report an Adverse Drug Reaction

Reporting of potential adverse drug reactions is important in order for us to continuously evaluate the benefits and risks of our products and take proactive action as warranted.

More from lundbeck

Research and Development

R&D of new and improved treatments is at the core of what we do.

Patients

We see patients as people and are committed to support the person behind.

Pipeline

Discover our projects and compounds in development.